Compassionate Use requests will be considered for individuals who test positive for SARS-CoV-2 and where there is reasonable basis to believe that the patient is infected with a susceptible variant.
Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications.
Study Type
EXPANDED_ACCESS
Administered intravenously (IV) single dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.